Exam (elaborations)
Test Bank For Clayton's Basic Pharmacology for Nurses 19th Edition By Bruce Clayton, Michelle Willihnganz, Samuel Gurevitz ( ) / 9780323796309 / Chapter 1-48 / Complete Questions and Answers A+
Course
Clayton\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Basic Pharmacology for Nurses 19t
Institution
Clayton\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\'s Basic Pharmacology For Nurses 19t
Test Bank For Clayton's Basic Pharmacology for Nurses 19th Edition By Bruce Clayton, Michelle Willihnganz, Samuel Gurevitz ( ) / 9780323796309 / Chapter 1-48 / Complete Questions and Answers A+
[Show more]
Preview 4 out of 408 pages
Uploaded on
December 15, 2024
Number of pages
408
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
Institution
Clayton's Basic Pharmacology for Nurses 19t
Course
Clayton's Basic Pharmacology for Nurses 19t
$17.99
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Test Bank For Clayton’s Basic Pharmacology for Nurses 19th EditionBy
8 8 8 8 8 8 8 8 8 8 8
Michelle J. Willihnganz, Samuel L. Gurevitz, Bruce Clayton Complete
8 8 8 8 8 8 8 8
,Chapter 01: Drug Definitions, Standards, and Information Sources Willihnganz:
8 8 8 8 8 8 8 8 8
Clayton’s Basic Pharmacology for Nurses, 19th Edition
8 8 8 8 8 8
MULTIPLE CHOICE 8
1. Which name identifies a drug listed by the US Food andD
8 8 8 8 8 8 8 8 8 8 8
rug Administration (FDA)?
8 8
a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: C 8
The official name is the name under which a drug is listed by t
8 8 8 8 8 8 8 8 8 8 8 8 8
he FDA. The brand name, or trademark, is the name given to a
8 8 8 8 8 8 8 8 8 8 8 8 8
drug by its manufacturer. The nonproprietary, or generic, nam
8 8 8 8 8 8 8 8
e is provided by the United States Adopted Names Council.
8 8 8 8 8 8 8 8 8
DIF: Cognitive Level: Knowledge REF: p. 9 8 8 8 8
OBJ: 1NAT: NCLEX Client Needs Category: Safe, Effective Care
8 8 8 8 8 8 8 8 8
Environment TOP: Nursing Process Step: Assessment 8 8 8 8 8
CON: 8
Patient Education 8
2. Which source contains information specific to nutritional supplements?
8 8 8 8 8 8 8
a. USP Dictionary of USAN &International Drug Names
8 8 8 8 8 8 8
b. Natural Medicines Comprehensive Database 8 8 8
c. United States Pharmacopoeia/National Formulary (USP NF)
8 8 8 8 8
d. Drug Interaction Facts 8 8
ANS: C 8
United States Pharmacopoeia/National Formulary contains information specific to nutritionals
8 8 8 8 8 8 8 8 8
upplements. USP Dictionary of USAN & International Drug Names is a compilation of drugna
8 8 8 8 8 8 8 8 8 8 8 8 8 8
mes, pronunciation guide, and possible future FDA approved drugs; it does not include nutrition
8 8 8 8 8 8 8 8 8 8 8 8 8
al supplements. Natural Medicines Comprehensive Database contains
8 8 8 8 8 8
evidence-
based information on herbal medicines and herbal combination products; it does notinclude infor
8 8 8 8 8 8 8 8 8 8 8 8 8
mation specific to nutritional supplements. Drug Interaction Facts contains comprehensive info
8 8 8 8 8 8 8 8 8 8
rmation on drug interaction facts; it does not include nutritional supplements.
8 8 8 8 8 8 8 8 8 8
DIF: Cognitive Level: Knowledge REF: p. 4 8 8 8 8
OBJ: 3NAT: NCLEX Client Needs Category: Physiological Integri
8 8 8 8 8 8 8 8
ty
TOP: Nursing Process Step: Assessment
8 CON: Nutrition | Patient Education 8 8 8 8 8 8 8
3. Which drug reference contains drug monographs that describe all drugs in a therapeutic class?
8 8 8 8 8 8 8 8 8 8 8 8 8
a. Drug Facts and Comparisons 8 8 8
,Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
8 8 8 8 8 8 8 8 8 3
b. Drug Interaction Facts 8 8
c. Handbook on Injectable Drugs 8 8 8
d. Martindale—The Complete Drug Reference 8 8 8
ANS: A 8
Drug Facts and Comparisons contains drug monographs that describe all drugs in ather
8 8 8 8 8 8 8 8 8 8 8 8 8
apeutic class. Monographs are formatted as tables to allow comparison of similarproduct
8 8 8 8 8 8 8 8 8 8 8 8
s, brand names, manufacturers, cost indices, and available dosage forms Online version
8 8 8 8 8 8 8 8 8 8 8 8
is available.
8
DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 8 8 8 8 8 8
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
888 8 8 8 8 8 8
TOP: Nursing Process Step: Assessment
8 CON: Safety | Patient Education | Clinical Judgment
8 8 8 8 88 8 8 8 8
4. Which drug reference contains monographs about virtually every single-
8 8 8 8 8 8 8 8
entity drug availablein the United States and describes therapeutic uses of drugs, including app
8 8 8 8 8 8 8 8 8 8 8 8 8 8
roved and unapproved uses?8 8 8
a. Martindale: The Complete Drug Reference 8 8 8 8
b. AHFS Drug Information 8 8
c. Drug Reference 8
d. Drug Facts and Comparisons 8 8 8
ANS: B 8
AHFS Drug Information contains monographs about virtually every single-
8 8 8 8 8 8 8 8
entity drug available in the United States and describes therapeutic uses of drugs, including appro
8 8 8 8 8 8 8 8 8 8 8 8 8 8
ved andunapproved uses.
8 8 8
DIF: Cognitive Level: Knowledge REF: p. 4 Table 1.2 8 8 8 8 8 8
OBJ: 3 NAT: NCLEX Client Needs Category: Physiological Integrity
888 8 8 8 8 8 8
TOP: Nursing Process Step: Planning
8 CON: Safety | Patient Education | Clinical Judgment
8 8 8 8 88 8 8 8 8
5. Which online drug reference makes available to healthcare providers and the public a standa
8 8 8 8 8 8 8 8 8 8 8 8 8
rd, comprehensive, up-to-date look up and downloadable resource about medicines?
8 8 8 8 8 8 8 8 8
a. American Drug Index 8 8
b. American Hospital Formulary 8 8
c. DailyMed
d. Drug Reference 8
ANS: C 8
DailyMed makes available to healthcare providers and the public a standard, comprehensive,up
8 8 8 8 8 8 8 8 8 8 8 8
-to-
date look up and downloadable resource about medicines. The American Drug Index isnot appr
8 8 8 8 8 8 8 8 8 8 8 8 8 8
opriate for patient use. The American Hospital Formulary is not appropriate for patient use. Th
8 8 8 8 8 8 8 8 8 8 8 8 8 8
e drug reference is not appropriate for patient use.
8 8 8 8 8 8 8 8
DIF: Cognitive Level: Knowledge REF: p. 3 | p. 4 8 8 8 8 8 8 8
OBJ: 3NAT: NCLEX Client Needs Category: Physiological Integri
8 8 8 8 8 8 8 8
ty
TOP: Nursing Process Step: Implementation
8 8 8 8
CON: Safety | Patient Education | Clinical Judgment
8 8 8 8 8 8 8
6. Which legislation authorizes the FDA to determine the safety of a drug before its marketing?
8 8 8 8 8 8 8 8 8 8 8 8 8 8
a. Federal Food, Drug, and Cosmetic Act (1938) 8 8 8 8 8 8
b. Durham Humphrey Amendment (1952) 8 8 8
, Test Bank For Clayton’s Basic Pharmacology for Nurses 19th Edition
8 8 8 8 8 8 8 8 8 4
c. Controlled Substances Act (1970) 8 8 8
d. Kefauver Harris Drug Amendment (1962) 8 8 8 8
ANS: A 8
The Federal Food, Drug, and Cosmetic Act of 1938 authorized the FDA to determine the safety
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
of all drugs before marketing. Later amendments and acts helped tighten FDA control and ensur
8 8 8 8 8 8 8 8 8 8 8 8 8 8
e drug safety. The Durham Humphrey Amendment defines the kinds of drugs that cannot be use
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
d safely without medical supervision and restricts their sale to prescription by a licensed practiti
8 8 8 8 8 8 8 8 8 8 8 8 8 8
oner. The Controlled Substances Act addresses only controlled substances andtheir categorizatio
8 8 8 8 8 8 8 8 8 8 8
n. The Kefauver Harris Drug Amendment ensures drug efficacy and greaterdrug safety. Drug m
8 8 8 8 8 8 8 8 8 8 8 8 8 8
anufacturers are required to prove to the FDA the effectiveness of their products before marketin
8 8 8 8 8 8 8 8 8 8 8 8 8 8
g them.
8
DIF: Cognitive Level: Knowledge REF: p. 5 Table l.3 8 8 8 8 8 8
OBJ: 5 8
NAT: NCLEX Client Needs Category: Physiological Integrity 8 8 8 8 8 8 8
TOP: Nursing Process Step: Assessment
8 8 8 8
CON: Safety | Patient Education | Evidence | Health Care Law
8 8 8 8 8 8 8 8 8 8
7. Which classification does meperidine (Demerol) fall under?
8 8 8 8 8 8
a. I
b. II
c. III
d. IV
ANS: B 8
Meperidine (Demerol) is a Schedule II drug; it has a high potential for abuse and may lead tosev
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
ere psychological and physical dependence. Schedule I drugs have high potential for abuseand n
8 8 8 8 8 8 8 8 8 8 8 8 8 8
o recognized medical use. Schedule III drugs have some potential for abuse. Use may lead to lo
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
w to moderate physical dependence or high psychological dependence. Schedule IVdrugs have
8 8 8 8 8 8 8 8 8 8 8 8 8
low potential for abuse. Use may lead to limited physical or psychological dependence.
8 8 8 8 8 8 8 8 8 8 8 8
DIF: Cognitive Level: Knowledge REF: p. 10 8 8 8 8
OBJ: 2NAT: NCLEX Client Needs Category: Safe, Effective Care
8 8 8 8 8 8 8 8 8 8
Environment
TOP: Nursing Process Step: Assessment
8 CON: Patient Education | Addiction | Pain
8 8 8 8 8 8 8 8 8
8. Which action would the FDA take to expedite drug development and approval for an outbreakof
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
smallpox?
a. List smallpox as a health orphan disease.
8 8 8 8 8 8
b. Omit the preclinical research phase. 8 8 8 8
c. Extend the clinical research phase. 8 8 8 8
d. Fast track the investigational drug. 8 8 8 8
ANS: D 8
Once the Investigational New Drug Application has been approved, the drug can receive highest
8 8 8 8 8 8 8 8 8 8 8 8 8
8priority within the agency, which is called fast tracking. A smallpox outbreak would become a p
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
riority concern in the world. Orphan diseases are not researched in a priority manner. Preclinical
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
research is not omitted. Extending any phase of the research would meana longer time to develo
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
p a vaccine. The FDA must ensure that all phases of the preclinical andclinical research phase hav
8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8 8
e been completed in a safe manner.
8 8 8 8 8 8
DIF: Cognitive Level: Knowledge 8 8 REF: p. 7 888 8 OBJ: 5 8